Evogene Unveils AI Innovations at BIO-Europe Spring 2026 Conference in Lisbon

Evogene Showcases AI-Driven Innovations at BIO-Europe Spring 2026 Conference

Evogene Ltd., a leader in computational chemistry, prepares to showcase its cutting-edge advancements in AI-driven small-molecule discovery at the upcoming BIO-Europe Spring 2026 conference in Lisbon, Portugal. Scheduled from March 23 to 25, the event will highlight the latest innovations in the pharmaceutical and agricultural sectors, where Evogene is making significant strides. Dr. Gabi Tarcic, Chief Development Officer, and Dr. Olga Nissan, VP of Business Development, represent the company at this prominent gathering, poised to engage with industry stakeholders and share insights on breakthroughs in generative AI.

During the conference, Dr. Nissan is set to deliver an oral presentation on March 24, where she will detail Evogene’s recent technological advancements, particularly emphasizing the capabilities of ChemPass AI™. This innovative AI system is designed to facilitate collaborative drug discovery by enabling the rapid navigation of extensive chemical spaces and the creation of novel small molecules. By optimizing these compounds across essential parameters, ChemPass AI™ enhances the success rates of development projects, thereby addressing critical needs in the pharmaceutical and agricultural industries. The emphasis on AI-driven molecular design combined with experimental validation positions Evogene as a frontrunner in the quest for effective solutions to real-world challenges in these sectors.

Evogene’s focus on technological innovation and industry collaboration underscores its commitment to addressing pressing industry challenges. By participating in major conferences like BIO-Europe Spring, the company not only presents its advancements but also fosters relationships with pharmaceutical and biotech partners who can leverage its unique capabilities. Those attending the event are encouraged to arrange one-on-one meetings with Evogene representatives to explore synergies and potential collaborative efforts.

In addition to showcasing its technological innovations, Evogene also shares its vision for future developments within its pharmaceutical division through forward-looking statements. As the company positions itself at the forefront of AI and chemical research, it is dedicated to generating breakthrough products that can significantly impact both the pharmaceutical and agricultural landscapes. For more information about the conference and Evogene's innovations, participants can register online and explore the company’s offerings on its official website.